The importance of bone integrity through the breast cancer continuum
01 Sep 2017
During the 6th Asia-Pacific Breast Cancer Summit, Professor Michael Gnant emphasized the need to maintain bone integrity in patients with breast cancer. Professor Gnant’s presentation highlighted the need to initiate early bone-targeted treatment in patients with breast cancer and bone metastases to prevent debilitating skeletal-related events (SREs). Patients with early-stage breast cancer receiving adjuvant aromatase inhibitor (AI) therapy also require bone-targeted treatment to prevent fractures related to cancer treatment-induced bone loss (CTIBL).
Related MIMS Drugs